← back to search

Florence Pache

Humboldt-Universität zu Berlin · DE
Area of research
Pathology and Forensic Medicine · Neurology
Research interest
Research interests include Multiple Sclerosis Research Studies, Peripheral Neuropathies and Disorders, Systemic Lupus Erythematosus Research, and Autoimmune Neurological Disorders and Treatments.
h-index
31
citations
5,111
works
77
NIH funding
primary concept
email

Recent publications

Retrospective In Silico Analysis of Routine Laboratory Data Supports a Specific Association of Epstein–Barr Virus and Multiple Sclerosis
European Journal of Neurology 2025cited by 1position: middledoi
Correction to: Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2024cited by 9position: middledoi
Broad Analysis of Serum and Intrathecal Antimicrobial Antibodies in Multiple Sclerosis Underscores Unique Role of Epstein-Barr Virus
Neurology Neuroimmunology & Neuroinflammation 2024cited by 4position: firstdoi
Update on the diagnosis and treatment of neuromyelitis optica spectrum disorders (NMOSD) – revised recommendations of the Neuromyelitis Optica Study Group (NEMOS). Part II: Attack therapy and long-term management
Journal of Neurology 2023cited by 219position: middledoi
Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients
Journal of Neuroinflammation 2022cited by 161position: middledoi
Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosis
Multiple Sclerosis Journal 2022cited by 18position: middledoi
C3 and C4 complement levels in AQP4-IgG-positive NMOSD and in MOGAD
Journal of Neuroimmunology 2021cited by 31position: firstdoi
Successful plasmapheresis and immunoglobulin treatment for severe lipid storage myopathy: Doing the right thing for the wrong reason
Neuropathology and Applied Neurobiology 2021cited by 4position: middledoi
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disorders
Neurology 2019cited by 47position: middledoi
Apheresis therapies for NMOSD attacks
Neurology Neuroimmunology & Neuroinflammation 2018cited by 231position: middledoi
Association of Visual Impairment in Neuromyelitis Optica Spectrum Disorder With Visual Network Reorganization
JAMA Neurology 2018cited by 49position: middledoi
Vaccines and the association with relapses in patients with neuromyelitis optica spectrum disorder
Multiple Sclerosis and Related Disorders 2018cited by 46position: middledoi
Immunotherapies in neuromyelitis optica spectrum disorder: efficacy and predictors of response
Journal of Neurology Neurosurgery & Psychiatry 2017cited by 151position: middledoi
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome
Journal of Neuroinflammation 2016cited by 889position: middledoi
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin
Journal of Neuroinflammation 2016cited by 427position: middledoi
Human cerebrospinal fluid monoclonal <i>N</i> -methyl-D-aspartate receptor autoantibodies are sufficient for encephalitis pathogenesis
Brain 2016cited by 293position: middledoi
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome
Journal of Neuroinflammation 2016cited by 250position: middledoi
Influence of female sex and fertile age on neuromyelitis optica spectrum disorders
Multiple Sclerosis Journal 2016cited by 80position: middledoi
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study
Journal of Neurology 2016cited by 63position: middledoi
Brain parenchymal damage in neuromyelitis optica spectrum disorder – A multimodal MRI study
European Radiology 2016cited by 58position: firstdoi
Neuromyelitis optica: Evaluation of 871 attacks and 1,153 treatment courses
Annals of Neurology 2015cited by 430position: middledoi
Interruption of Macrophage-Derived IL-27(p28) Production by IL-10 during Sepsis Requires STAT3 but Not SOCS3
The Journal of Immunology 2014cited by 50position: middledoi
Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27
Journal of Leukocyte Biology 2014cited by 25position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Klemens Ruprecht · Heidelberg University6 papers (2016–2025)Friedemann Paul · Max Delbrück Center6 papers (2016–2021)Sven Jarius · Heidelberg University4 papers (2016–2025)Patrick Schindler · Max Delbrück Center3 papers (2022–2025)Carolin Otto · Humboldt-Universität zu Berlin3 papers (2022–2025)Markus Bosmann · Boston University2 papers (2014–2014)Marius Ringelstein · Antea Group (France)2 papers (2016–2021)Peter A. Ward · Dorset County Hospital2 papers (2014–2014)Orhan Aktaş · Düsseldorf University Hospital2 papers (2016–2021)Alexander U. Brandt · Eli Lilly (United States)2 papers (2016–2018)Judith Bellmann–Strobl · Humboldt-Universität zu Berlin2 papers (2018–2021)Lutz Harms · Humboldt-Universität zu Berlin2 papers (2016–2021)Hanna Zimmermann · German Center for Diabetes Research2 papers (2016–2018)Carsten Finke · Max Delbrück Center2 papers (2016–2018)Moritz Niederschweiberer · Mayo Clinic2 papers (2022–2024)Helena Radbruch · Berlin Institute of Health at Charité - Universitätsmedizin Berlin2 papers (2016–2021)Ingo Kleiter · Dentsply Sirona (United States)2 papers (2016–2021)Mathias Müller · University of Veterinary Medicine Vienna2 papers (2014–2014)Brigitte Wildemann · Heidelberg University2 papers (2024–2025) · 2 papers (2014–2014)